Apellis Pharmaceuticals (NASDAQ:APLS) PT Lowered to $56 00 etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Point72 Asset Management L.P. trimmed its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 34.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,239,361 shares of the company’s stock after selling 640,363 shares during the period. Point72 Asset Management […]
Bank of America upgraded shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Tuesday morning, Marketbeat reports. They currently have $85.00 target price on the stock, up from their prior target price of $52.00. Several other brokerages have also recently […]
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) gapped down prior to trading on Wednesday . The stock had previously closed at $48.66, but opened at $46.08. Apellis Pharmaceuticals shares last traded at $49.45, with a volume of 546,920 shares traded. Analyst Upgrades and Downgrades Several equities analysts have recently issued reports on […]
Handelsbanken Fonder AB lifted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 14.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 17,200 shares of the company’s stock after acquiring an additional 2,200 shares during the period. Handelsbanken Fonder […]